Mark J. Caulfield
Preventive Cardiology
Queen Mary University of London
About
Mark J. Caulfield works in Preventive Cardiology affiliated with Queen Mary University of London.
Mark J. Caulfield is Professor of Clinical Pharmacology at Queen Mary University of London and Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry. He serves as a member of the Barts Health NHS Trust Board. He previously directed the William Harvey Research Institute from 2002 to 2020 and has conducted research in molecular genetics of hypertension and cardiovascular health.
Research focus
Molecular Genetics of HypertensionCardiovascular GenomicsHypertension ManagementPharmacogenomics in Cardiovascular TherapyGenetic Risk Factors for Blood Pressure
Impact
595 pubs · 132,593 cites · h-index 131
Training
Degree in Medicine
London Hospital Medical College
1984
Affiliations
Work Experience
Vice Principal for Health
Queen Mary University of London · 2022 - Present
Professor of Clinical Pharmacology
Queen Mary University of London
Director of the William Harvey Research Institute
Queen Mary University of London · 2002 - 2020
Chief Scientist
Genomics England · 2013 - Present
President of the British Hypertension Society
British Hypertension Society · 2009 - 2011